Landauer (LDR) 10-Q 10 Feb 14 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Dec. 31, 2013	Jan. 28, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Dec-13	'
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'
Entity Registrant Name	'LANDAUER INC	'
Trading Symbol	'ldr	'
Entity Central Index Key	'0000825410	'
Current Fiscal Year End Date	'--09-30	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	9,537,544

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$13,272	$11,184
Receivables, net of allowances of $570 and $600 respectively	34,178	38,419
Inventories	8,301	9,539
Prepaid income taxes	2,671	3,132
Prepaid expenses and other current assets	5,220	4,019
Current assets	63,642	66,293
Property, plant and equipment, at cost	104,316	107,446
Accumulated depreciation and amortization	-53,407	-55,514
Net property, plant and equipment	50,909	51,932
Equity in joint ventures	22,600	23,942
Goodwill	86,529	84,436
Intangible assets, net of accumulated amortization of $14,790 and $13,605, respectively	37,022	37,161
Dosimetry devices, net of accumulated depreciation of $9,915 and $9,472, respectively	5,739	5,798
Other assets	7,704	7,271
Assets	274,145	276,833
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	6,036	6,310
Dividends payable	5,433	5,419
Deferred contract revenue	13,572	13,181
Accrued compensation and related costs	6,160	8,207
Other accrued expenses	6,217	7,531
Current liabilities	37,418	40,648
Non-current liabilities:	'	'
Long-term debt	143,785	142,785
Pension and postretirement obligations	13,308	13,047
Deferred income taxes	10,324	9,817
Other non-current liabilities	1,890	915
Non-current liabilities	169,307	166,564
Stockholders’ equity:	'	'
Preferred stock, $.10 par value per share, authorized 1,000,000 shares; none issued	'	'
Common stock, $.10 par value per share, authorized 20,000,000 shares; 9,615,711 and 9,575,926 issued and outstanding at December 31, 2013 and September 30, 2013 respectively	962	958
Additional paid in capital	39,653	39,465
Accumulated other comprehensive loss	-4,547	-4,456
Retained earnings	29,582	32,012
Landauer, Inc. stockholders' equity	65,650	67,979
Noncontrolling interest	1,770	1,642
Stockholders' equity	67,420	69,621
Liabilities and Stockholders’ Equity	$274,145	$276,833

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, except Share data, unless otherwise specified
Consolidated Balance Sheets [Abstract]	'	'
Receivables, allowances	$570	$600
Intangible assets, accumulated amortization	14,790	13,605
Dosimetry devices, accumulated depreciation	$9,915	$9,472
Preferred stock, par value	$0.10	$0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.10	$0.10
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	9,615,711	9,575,926
Common stock, shares outstanding	9,615,711	9,575,926

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements Of Operations [Abstract]	'	'
Service revenues	$31,894	$31,469
Product revenues	5,811	5,212
Net revenues	37,705	36,681
Costs and expenses:	'	'
Service costs	15,049	14,308
Product costs	3,158	2,255
Total cost of sales	18,207	16,563
Selling, general, and administrative	14,362	13,391
Acquisition and reorganization costs	111	0
Costs and expenses	32,680	29,954
Operating income	5,025	6,727
Equity in income of joint ventures	573	1,528
Interest expense, net	-892	-1,033
Other income, net	37	95
Income before taxes	4,743	7,317
Income taxes	1,496	2,274
Net income	3,247	5,043
Less: Net income attributed to noncontrolling interest	196	166
Net (loss) income attributed to Landauer, Inc.	$3,051	$4,877
Net (loss) income per share attributable to Landauer, Inc. shareholders:	'	'
Basic	$0.32	$0.52
Weighted average basic shares outstanding	9,422	9,336
Diluted	$0.32	$0.52
Weighted average diluted shares outstanding	9,467	9,385

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive Income (Loss) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Net income	$3,247	$5,043
Other comprehensive income:	'	'
Defined benefit pension and postretirement plans activity, net of tax	165	108
Foreign currency translation adjustment	-324	-622
Comprehensive income	3,088	4,529
Landauer, Inc. [Member]	'	'
Net income	3,051	4,877
Other comprehensive income:	'	'
Defined benefit pension and postretirement plans activity, net of tax	165	108
Foreign currency translation adjustment	-256	-624
Comprehensive income	2,960	4,361
Non-Controlling Interest [Member]	'	'
Net income	196	166
Other comprehensive income:	'	'
Foreign currency translation adjustment	-68	2
Comprehensive income	$128	$168

Consolidated_Statement_Of_Stoc

Consolidated Statement Of Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Non-Controlling Interest [Member]	Total
In Thousands, except Share data
Balance at Sep. 30, 2013	$958	$39,465	($4,456)	$32,012	$1,642	$69,621
Balance, shares at Sep. 30, 2013	9,575,926	'	'	'	'	9,575,926
Stock-based compensation arrangements	4	188	'	'	'	192
Stock-based compensation arrangements, shares	39,785	'	'	'	'	'
Dividends	'	'	'	-5,481	'	-5,481
Net income	'	'	'	3,051	196	3,247
Foreign currency translation adjustment	'	'	-256	'	-68	-324
Defined benefit pension and postretirement plans activity, net of tax	'	'	165	'	'	165
Balance at Dec. 31, 2013	$962	$39,653	($4,547)	$29,582	$1,770	$67,420
Balance, shares at Dec. 31, 2013	9,615,711	'	'	'	'	9,615,711

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net income	$3,247	$5,043
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	3,894	3,450
Equity in income of joint ventures	-573	-1,528
Dividends from joint ventures	1,340	1,892
Stock-based compensation and related net tax benefits	282	625
Current and long-term deferred taxes, net	292	7
Changes in operating assets and liabilities:	'	'
Decrease (increase) in accounts receivable, net	4,396	-1,114
Decrease in prepaid taxes	466	1,449
Increase in other operating assets, net	-88	-1,953
Decrease in accounts payable and other accrued liabilities	-3,502	-5,775
Increase in other operating liabilities, net	200	244
Net cash provided by operating activities	9,954	2,340
Cash flows used by investing activities:	'	'
Acquisition of property, plant and equipment	-1,071	-1,902
Acquisition of joint ventures and businesses, net of cash acquired	-1,800	'
Other investing activities, net	-719	-453
Net Cash used by investing activities	-3,590	-2,355
Cash flows provided (used) by financing activities:	'	'
Net borrowings on revolving credit facility	-21	'
Long-term borrowings - loan	14,000	4,300
Long-term borrowings - repayment	-13,000	'
Dividends paid to stockholders	-5,274	-5,229
Other financing activities, net	49	-248
Net cash used by financing activities	-4,246	-1,177
Effects of foreign currency translation	-30	56
Net increase (decrease) in cash and cash equivalents	2,088	-1,136
Opening balance - cash and cash equivalents	11,184	17,633
Ending balance - cash and cash equivalents	$13,272	$16,497

Basis_Of_Presentation_And_Cons

Basis Of Presentation And Consolidation	3 Months Ended
	Dec. 31, 2013
Basis Of Presentation And Consolidation [Abstract]	'
Basis Of Presentation And Consolidation	'
	(1)Basis of Presentation and Consolidation
	As used herein, the “Company” or “Landauer” refers to Landauer, Inc. and its subsidiaries.
	These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2013 and other financial information filed with the Securities and Exchange Commission (the “SEC”).
	The accounting policies followed by the Company are set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2013.  There have been no changes to the accounting policies for the three month period ended December 31, 2013.
	The results of operations for the three month period ended December 31, 2013 are not necessarily indicative of the results to be expected for the full fiscal year. The September 30, 2013 balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	In the opinion of  management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair statement of such financial statements.  Certain reclassifications have been made in the financial statements for comparative purposes.  These reclassifications have no effect on the results of operations or financial position of the Company.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Dec. 31, 2013
Recent Accounting Pronouncements [Abstract]	'
Recent Accounting Pronouncements	'
	(2)Recent Accounting Pronouncements
	In February 2013, the FASB issued new guidance on the presentation of comprehensive income. This guidance requires reclassification adjustments from other comprehensive income to be presented either in the financial statements or in the notes to the financial statements. The standard would not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the guidance would require an entity to provide enhanced disclosures to present separately by component reclassifications out of accumulated other comprehensive income. This guidance was adopted by the Company in the first quarter of fiscal 2014.  The adoption did not have a material impact on its consolidated financial statements.
	In March 2013, the FASB issued an accounting update that clarifies the applicable guidance for the release of the cumulative translation adjustment when an entity ceases to have a controlling financial interest in a subsidiary or a group of assets that is a business within a foreign entity.  The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice.  This guidance was adopted by the Company in the first quarter of fiscal 2014.  The adoption did not have a material impact on its consolidated financial statements.
	In July 2013, the FASB issued new guidance to reduce the diversity in presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. This requires an unrecognized tax benefit to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions listed in the guidance.  This guidance is effective for the Company in the first quarter of fiscal 2015.  The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	(3)Fair Value Measurements
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in a principal or most advantageous market.  Fair value is a market-based measurement that is determined based on inputs, which refer broadly to assumptions that market participants use in pricing assets or liabilities.  A fair value hierarchy with three tiers has been established to prioritize the inputs to valuation techniques used to measure fair value.  The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs.  Level 1 inputs include quoted prices in active markets for identical assets and liabilities.  Level 2 inputs consist of observable inputs other than quoted prices in active markets or indirectly observable through corroboration with observable market data.  Level 3 inputs are not observable in the market and include management’s own judgments about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.
	As of December 31, 2013 and September 30, 2013, the Company’s financial assets measured and recorded at fair value on a recurring basis were comprised of investments in trading securities, which are reported in other long-term assets.  The investments are held in a Rabbi trust for benefits under the Company’s deferred compensation plan.  Under the plan, participants designate investment options to serve as the basis for measurement of the notional value of their accounts.  The investments include a money market fund and mutual funds that are publicly traded.  The fair values of the shares or underlying securities of these funds are based on quoted market prices and, therefore, are categorized as Level 1 in the fair value hierarchy.
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements at December 31, 2013 Using
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
						(Level 3)
	Asset Category
	Cash equivalents	$	118	$	-	$	-
	Mutual funds		3,473		-		-
	Total financial assets at fair value	$	3,591	$	-	$	-
		Fair Value Measurements at September 30, 2013 Using
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
						(Level 3)
	Asset Category
	Cash equivalents	$	55	$	-	$	-
	Mutual funds		2,922		-		-
	Total financial assets at fair value	$	2,977	$	-	$	-
	As of December 31, 2013, the carrying amount of the Company’s long-term debt, which is categorized as Level 1 in the fair value hierarchy, approximated fair value as the stated interest rates were variable in relation to prevailing market rates.

Income_Per_Common_Share

Income Per Common Share	3 Months Ended
	Dec. 31, 2013
Income Per Common Share [Abstract]	'
Income Per Common Share	'
	(4)Income per Common Share
	Basic net income per share was computed by dividing net income available to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period.  Diluted net income per share was computed by dividing net income available to common stockholders for the period by the weighted average number of shares of common stock that would have been outstanding assuming dilution from stock-based compensation awards during the period.
		Three Months Ended
		December 31,
	(Dollars in Thousands, Except per Share)	2013		2012
	Basic Net Income per Share:
	Net income attributed to Landauer, Inc.	$	3,051	$	4,877
	Less:  Income allocated to unvested restricted stock		46		31
	Net income available to common stockholders	$	3,005	$	4,846
	Basic weighted average shares outstanding		9,422		9,336
	Net income per share - Basic	$	0.32	$	0.52
	Diluted Net Income per Share:
	Net income attributed to Landauer, Inc.	$	3,051	$	4,877
	Less:   Income allocated to unvested restricted stock		46		31
	Net income available to common stockholder	$	3,005	$	4,846
	Basic weighted average shares outstanding		9,422		9,336
	Effect of dilutive securities		45		49
	Diluted weighted averages shares outstanding		9,467		9,385
	Net income per share - Diluted	$	0.32	$	0.52
	On December 3, 2013, the Company declared a regular quarterly cash dividend in the amount of $0.55 per share for the fourth quarter of fiscal 2013. The dividends were paid on January 6, 2014 to shareholders of record as of December 23, 2013.

Employee_Benefit_Plans

Employee Benefit Plans	3 Months Ended
	Dec. 31, 2013
Employee Benefit Plans [Abstract]	'
Employee Benefit Plans	'
	(5)Employee Benefit Plans
	The components of net periodic benefit cost for pension and other benefits were as follows:
	Pension Benefits	Three Months Ended December 31,
		2013		2012
	Interest cost	$	375	$	340
	Expected return on plan assets		-377		-365
	Amortization of net loss		48		108
	Net periodic benefit cost	$	46	$	83
	Other Benefits	Three Months Ended December 31,
		2013		2012
	Service cost	$	15	$	17
	Interest cost		13		12
	Amortization of net (gain) loss		-3		-
	Net periodic benefit cost	$	25	$	29
	The Company, under the IRS minimum funding standards, has no required contributions to make to its defined benefit pension plan during fiscal 2014.
	The Company maintains 401(k) Retirement Savings Plans for certain employees, which may provide for employer matching contributions, and a supplemental defined contribution plan for certain executives, which provides for employer contributions at the discretion of the Company.  Amounts expensed for Company contributions under these plans during the first three months of fiscal 2014 and 2013 were $458 and $371, respectively.

Goodwill_And_Other_Intangibles

Goodwill And Other Intangibles	3 Months Ended
	Dec. 31, 2013
Goodwill And Other Intangible [Abstract]	'
Goodwill And Other Intangible	'
	(6)Goodwill and Other Intangibles
		Radiation Measurement		Medical		Medical		Total
				Physics		Products
	Balance as of September 30, 2013	$	20,456	$	22,611	$	41,369	$	84,436
	Increase related to acquisitions, net		-		-		2,019		2,019
	of subsequent  adjustments for
	deferred taxes
	Effects of foreign currency		74						74
	Accumulated goodwill impairment charges								-
	Goodwill, net as of December 31, 2013	$	20,530	$	22,611	$	43,388	$	86,529
	On December 23rd, 2013, the Company acquired a small German distributor on behalf of the Medical Products segment.  The preliminary purchase price allocation indicates an increase in customer lists of $772 and an increase in goodwill of $2,019.
	Intangible assets for the years ended December  31, were as follows:
			31-Dec-13				30-Sep-13
		Gross		Accumulated		Gross		Accumulated
		Carrying		Amortization		Carrying		Amortization
		Amount				Amount
	Customer lists	$	44,865	$	12,676	$	43,954	$	11,639
	Trademarks and tradenames		2,156		451		2,154		400
	Licenses and patents		4,214		1,106		4,080		1,009
	Other intangibles		577		557		577		557
	Intangible assets	$	51,812	$	14,790	$	50,765	$	13,605

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Abstract]	'
Accumulated Other Comprehensive Income (Loss)	'
	(7)Accumulated Other Comprehensive Income (Loss)
	Accumulated elements of other comprehensive income (loss) (“AOCI”), net of tax, are included in the stockholders’ equity section of the condensed consolidated balance sheets.  Changes in each component of AOCI are as follows:
		Foreign Currency Translation Adjustments		Pension and Postretirement Plans, net of tax		Total
	Balance at September 30, 2013	$	-178	$	-4,278	$	-4,456
	Other comprehensive income before reclassifications		-256		-		-256
	Amounts reclassified from accumulated other comprehensive income		-		165		165
	Net current period other comprehensive income		-256		165		-91
	Balance at December 31, 2013	$	-434	$	-4,113	$	-4,547
	Reclassifications out of accumulated other comprehensive income (loss) included in the computation of net periodic benefit costs (refer to Note 5 of the Notes to Consolidated Financial Statements for additional details regarding employee benefit plans) was as follows:
	Pension and Postretirement Plans	Three Months Ended December 31,
		2013		2012
	Amortization of net loss	$	45	$	108
	Provision for income taxes		120		-
	Total net of tax	$	165	$	108

Segment_Information

Segment Information	3 Months Ended
	Dec. 31, 2013
Segment Information [Abstract]	'
Segment Information	'
	(8)Segment Information
	During the first fiscal quarter of 2014, the Company changed the presentation of its reporting segments to separately disclose certain ‘corporate expenses’ that had previously been reported within the Radiation Measurement segment.  As a result, the current segment disclosures will reflect three reporting segments: Radiation Measurement, Medical Physics, Medical Products and one functional group: Corporate.  The following tables summarize financial information for each reportable segment:
		Three Months Ended December 31,
		2013		2012
	Revenues by segment:
	Radiation Measurement	$	27,741		26,403
	Medical Physics		7,739		7,589
	Medical Products		2,225		2,689
	Consolidated revenues	$	37,705		36,681
		Three Months Ended December 31,
		2013		2012
	Operating income (loss) by segment:
	Radiation Measurement	$	8,579		9,432
	Medical Physics		433		792
	Medical Products		-438		670
	Corporate		-3,549		-4,167
	Consolidated operating income	$	5,025		6,727

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Financial Assets Measured At Fair Value On A Recurring Basis	'
		Fair Value Measurements at December 31, 2013 Using
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
						(Level 3)
	Asset Category
	Cash equivalents	$	118	$	-	$	-
	Mutual funds		3,473		-		-
	Total financial assets at fair value	$	3,591	$	-	$	-
		Fair Value Measurements at September 30, 2013 Using
		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
						(Level 3)
	Asset Category
	Cash equivalents	$	55	$	-	$	-
	Mutual funds		2,922		-		-
	Total financial assets at fair value	$	2,977	$	-	$	-

Income_Per_Common_Share_Tables

Income Per Common Share (Tables)	3 Months Ended
	Dec. 31, 2013
Income Per Common Share [Abstract]	'
Computation Of Net Income (Loss) Per Share	'
		Three Months Ended
		December 31,
	(Dollars in Thousands, Except per Share)	2013		2012
	Basic Net Income per Share:
	Net income attributed to Landauer, Inc.	$	3,051	$	4,877
	Less:  Income allocated to unvested restricted stock		46		31
	Net income available to common stockholders	$	3,005	$	4,846
	Basic weighted average shares outstanding		9,422		9,336
	Net income per share - Basic	$	0.32	$	0.52
	Diluted Net Income per Share:
	Net income attributed to Landauer, Inc.	$	3,051	$	4,877
	Less:   Income allocated to unvested restricted stock		46		31
	Net income available to common stockholder	$	3,005	$	4,846
	Basic weighted average shares outstanding		9,422		9,336
	Effect of dilutive securities		45		49
	Diluted weighted averages shares outstanding		9,467		9,385
	Net income per share - Diluted	$	0.32	$	0.52

Employee_Benefit_Plans_Tables

Employee Benefit Plans (Tables)	3 Months Ended
	Dec. 31, 2013
Employee Benefit Plans [Abstract]	'
Schedule Of Net Periodic Benefit Costs	'
	Pension Benefits	Three Months Ended December 31,
		2013		2012
	Interest cost	$	375	$	340
	Expected return on plan assets		-377		-365
	Amortization of net loss		48		108
	Net periodic benefit cost	$	46	$	83
	Other Benefits	Three Months Ended December 31,
		2013		2012
	Service cost	$	15	$	17
	Interest cost		13		12
	Amortization of net (gain) loss		-3		-
	Net periodic benefit cost	$	25	$	29

Goodwill_And_Other_Intangible_

Goodwill And Other Intangible (Tables)	3 Months Ended
	Dec. 31, 2013
Goodwill And Other Intangible [Abstract]	'
Changes In The Carrying Amount Of Goodwill, By Reportable Segment	'
		Radiation Measurement		Medical		Medical		Total
				Physics		Products
	Balance as of September 30, 2013	$	20,456	$	22,611	$	41,369	$	84,436
	Increase related to acquisitions, net		-		-		2,019		2,019
	of subsequent  adjustments for
	deferred taxes
	Effects of foreign currency		74						74
	Accumulated goodwill impairment charges								-
	Goodwill, net as of December 31, 2013	$	20,530	$	22,611	$	43,388	$	86,529
Other Intangible Assets	'
			31-Dec-13				30-Sep-13
		Gross		Accumulated		Gross		Accumulated
		Carrying		Amortization		Carrying		Amortization
		Amount				Amount
	Customer lists	$	44,865	$	12,676	$	43,954	$	11,639
	Trademarks and tradenames		2,156		451		2,154		400
	Licenses and patents		4,214		1,106		4,080		1,009
	Other intangibles		577		557		577		557
	Intangible assets	$	51,812	$	14,790	$	50,765	$	13,605

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Abstract]	'
Changes In Each Component Of AOCI	'
		Foreign Currency Translation Adjustments		Pension and Postretirement Plans, net of tax		Total
	Balance at September 30, 2013	$	-178	$	-4,278	$	-4,456
	Other comprehensive income before reclassifications		-256		-		-256
	Amounts reclassified from accumulated other comprehensive income		-		165		165
	Net current period other comprehensive income		-256		165		-91
	Balance at December 31, 2013	$	-434	$	-4,113	$	-4,547
Summary Of Reclassifications Out Of Accumulated Other Comprehensive Income (Loss)	'
	Pension and Postretirement Plans	Three Months Ended December 31,
		2013		2012
	Amortization of net loss	$	45	$	108
	Provision for income taxes		120		-
	Total net of tax	$	165	$	108

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Dec. 31, 2013
Segment Information [Abstract]	'
Financial Information For Each Reportable Segment	'
		Three Months Ended December 31,
		2013		2012
	Revenues by segment:
	Radiation Measurement	$	27,741		26,403
	Medical Physics		7,739		7,589
	Medical Products		2,225		2,689
	Consolidated revenues	$	37,705		36,681
		Three Months Ended December 31,
		2013		2012
	Operating income (loss) by segment:
	Radiation Measurement	$	8,579		9,432
	Medical Physics		433		792
	Medical Products		-438		670
	Corporate		-3,549		-4,167
	Consolidated operating income	$	5,025		6,727

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (Quoted Prices in Active Markets for Identical Assets (Level 1) [Member], USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Cash equivalents	$118	$55
Mutual funds	3,473	2,922
Total financial assets at fair value	$3,591	$2,977

Income_Per_Common_Share_Detail

Income Per Common Share (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Income Per Common Share [Abstract]	'	'
Net income attributed to Landauer, Inc.	$3,051	$4,877
Less: Income allocated to unvested restricted stock	46	31
Net income available to common stockholders	$3,005	$4,846
Basic weighted averages shares outstanding	9,422	9,336
Net (loss) income per share - Basic	$0.32	$0.52
Effect of dilutive securities	45	49
Diluted weighted averages shares outstanding	9,467	9,385
Net (loss) income per share - Diluted	$0.32	$0.52
Dividends paid per share	$0.55	'

Employee_Benefit_Plans_Narrati

Employee Benefit Plans (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Employee Benefit Plans [Abstract]	'	'
Employer contribution for defined contribution plans	$458	$371

Employee_Benefit_Plans_Schedul

Employee Benefit Plans (Schedule Of Net Periodic Benefit Costs) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Pension Benefits [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Interest cost	$375	$340
Expected return on plan assets	-377	-365
Amortization of net (gain) loss	48	108
Net periodic benefit cost	46	83
Other Benefits [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Service cost	15	17
Interest cost	13	12
Amortization of net (gain) loss	-3	'
Net periodic benefit cost	$25	$29

Goodwill_And_Other_Intangible_1

Goodwill And Other Intangible (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Dec. 23, 2013	Dec. 31, 2013
Acquired Finite-Lived Intangible Assets [Line Items]	'	'
increase in goodwill	$2,019	$2,019
Increase in customer lists	772	'
Medical Products [Member]	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'
increase in goodwill	'	$2,019

Goodwill_And_Other_Intangible_2

Goodwill And Other Intangible (Changes In The Carrying Amount Of Goodwill, By Reportable Segment) (Details) (USD $)	0 Months Ended	3 Months Ended				3 Months Ended
In Thousands, unless otherwise specified	Dec. 23, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2013
			Radiation Measurement [Member]	Medical Physics [Member]	Medical Physics [Member]	Medical Products [Member]
Goodwill	'	$84,436	$20,456	$22,611	$22,611	$41,369
Increase related to acquisitions, net of subsequent adjustments for deferred taxes	2,019	2,019	'	'	'	2,019
Effects of foreign currency	'	74	74	'	'	'
Goodwill	'	$86,529	$20,530	$22,611	$22,611	$43,388

Goodwill_And_Other_Intangible_3

Goodwill And Other Intangible (Other Intangible Assets) (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$51,812	$50,765
Accumulated Amortization	14,790	13,605
Customer Lists [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	44,865	43,954
Accumulated Amortization	12,676	11,639
Trademarks And Tradenames [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	2,156	2,154
Accumulated Amortization	451	400
Licenses And Patents [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	4,214	4,080
Accumulated Amortization	1,106	1,009
Other Intangibles [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	577	577
Accumulated Amortization	$557	$557

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) (Changes In Each Component Of AOCI) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	($4,456)
Other comprehensive income before reclassifications	-256
Amounts reclassified from accumulated other comprehensive income	165
Net current period other comprehensive income	-91
Balance	-4,547
Foreign Currency Translation Adjustments [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	-178
Other comprehensive income before reclassifications	-256
Net current period other comprehensive income	-256
Balance	-434
Pension And Postretirement Plans [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	-4,278
Amounts reclassified from accumulated other comprehensive income	165
Net current period other comprehensive income	165
Balance	($4,113)

Accumulated_Other_Comprehensiv3

Accumulated Other Comprehensive Income (Loss) (Summary Of Reclassifications Out Of Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Provision for income taxes	$1,496	$2,274
Total net of tax	-165	-108
Reclassification out of Accumulated Other Comprehensive Income [Member] | Pension And Postretirement Plans [Member]	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Amortization of net loss	45	108
Provision for income taxes	120	'
Total net of tax	$165	$108

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
	segment
Reporting segments	3	'
Revenues	$37,705	$36,681
Operating income (loss)	5,025	6,727
Radiation Measurement [Member]	'	'
Revenues	27,741	26,403
Operating income (loss)	8,579	9,432
Medical Physics [Member]	'	'
Revenues	7,739	7,589
Operating income (loss)	433	792
Medical Products [Member]	'	'
Revenues	2,225	2,689
Operating income (loss)	-438	670
Corporate [Member]	'	'
Operating income (loss)	($3,549)	($4,167)